Korean Drug Co. Ltd (014570) — Financial Flexibility Index

Latest as of March 2026: 0.48x

Korean Drug Co. Ltd (014570) has a Financial Flexibility Index of 0.48x as of March 2026. Free cash flow of ₩6.73 Billion (operating CF ₩6.60 Billion minus capex ₩131.88 Million) represents 0% of total liabilities (₩14.09 Billion). Check how strategically is Korean Drug Co. Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

0.48x
Free Cash Flow / Total Liabilities

Free Cash Flow

₩6.73 Billion
Operating CF − Capex

Total Liabilities

₩14.09 Billion
KRW

Capital Expenditures

₩131.88 Million
KRW

Korean Drug Co. Ltd Financial Flexibility Index (2014–2025)

Historical Financial Flexibility Index trend for Korean Drug Co. Ltd across 12 annual periods. See 014570 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Korean Drug Co. Ltd (2014–2025)

Year-by-year free cash flow to debt coverage for Korean Drug Co. Ltd. For the full company profile including market capitalisation, see 014570 company net worth.

Year Flexibility Index Free Cash Flow (KRW) Operating CF Total Liabilities YoY Change
2025 1.21x ₩13.59 Billion ₩13.11 Billion ₩11.25 Billion ▲ +120.3%
2024 0.55x ₩5.91 Billion ₩4.87 Billion ₩10.78 Billion ▲ +75.8%
2023 0.31x ₩3.94 Billion ₩-2.00 Billion ₩12.62 Billion ▼ -74.5%
2022 1.22x ₩12.01 Billion ₩5.91 Billion ₩9.80 Billion ▲ +46.7%
2021 0.83x ₩9.95 Billion ₩8.81 Billion ₩11.92 Billion ▼ -20.3%
2020 1.05x ₩13.07 Billion ₩12.33 Billion ₩12.47 Billion ▲ +22.2%
2019 0.86x ₩9.26 Billion ₩6.21 Billion ₩10.80 Billion ▲ +22.9%
2018 0.70x ₩7.09 Billion ₩5.79 Billion ₩10.16 Billion ▲ +333.7%
2017 0.16x ₩1.58 Billion ₩447.20 Million ₩9.82 Billion ▼ -64.6%
2016 0.45x ₩4.42 Billion ₩3.96 Billion ₩9.75 Billion ▼ -38.4%
2015 0.74x ₩7.01 Billion ₩6.13 Billion ₩9.52 Billion ▲ +97.1%
2014 0.37x ₩5.00 Billion ₩4.46 Billion ₩13.38 Billion —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities